Humana (HUM) Stock
Key stats
- Market cap
- $50.14B
- Price / Earnings ratio
- 38.7x
- EPS (TTM)
- $10.65
- Volume
- Loading
- 52-week high
- $456.50
- 52-week low
- $163.11
- Dividend yield
- 0.64%
- Dividend amount (latest)
- $0.89
- EPS vs analyst estimate
- +13.3%Q3 FY25 · $3.24 vs $2.86
- Next earnings report
- 4 Nov 2026
Source: third-party data provider, as of October 31, 2026
EPS estimate: analyst consensus
Compare with HUM
Recent news

Humana Board Declares Payment of Quarterly Dividend to Stockholders
Humana Board Declares Payment of Quarterly Dividend to Stockholders
HUM

Humana Gains From Premium Growth Despite Rising Benefit Costs
Humana Gains From Premium Growth Despite Rising Benefit Costs
HUM

Should Value Investors Buy Humana (HUM) Stock?
Should Value Investors Buy Humana (HUM) Stock?
HUM

3.2 Million Seniors Will Lose Their Medicare Advantage Plans in 2027 — and Their Replacement Options Are Shrinking
3.2 Million Seniors Will Lose Their Medicare Advantage Plans in 2027 — and Their Replacement Options Are Shrinking
HUM
News tone: automated (AI) classification of the article's content, not a price prediction.
Technical indicators
- RSI 14
- 53.99
- MACD 12/26/9
- 5.86
- EMA 9 of MACD
- 7.30
- MACD histogram
- -1.44
- SMA 50
- $400.35
- Price above SMA 50
- EMA 50
- $401.41
- Price above EMA 50
- SMA 200
- $307.64
- Price above SMA 200
- EMA 200
- $323.16
- Price above EMA 200
Calculated by Gotrade from daily closing prices, as of October 29, 2026. Technical data, not a recommendation.
Analyst ratings
Analyst consensus: Buy
Based on 10 analyst ratings
Third-party analyst opinion, not a recommendation from Gotrade.
Financials
Performance
Debt & Balance Sheet
Revenue to Profit
2025Earnings
The market is expecting earnings per share of $1.35 for this quarter. The company has not yet shared when it is announcing earnings.
Source: third-party data provider
Latest news

Humana Board Declares Payment of Quarterly Dividend to Stockholders
Humana Board Declares Payment of Quarterly Dividend to Stockholders
HUM

Humana Gains From Premium Growth Despite Rising Benefit Costs
Humana Gains From Premium Growth Despite Rising Benefit Costs
HUM

Should Value Investors Buy Humana (HUM) Stock?
Should Value Investors Buy Humana (HUM) Stock?
HUM

3.2 Million Seniors Will Lose Their Medicare Advantage Plans in 2027 — and Their Replacement Options Are Shrinking
3.2 Million Seniors Will Lose Their Medicare Advantage Plans in 2027 — and Their Replacement Options Are Shrinking
HUM

Humana's CenterWell Expansion Gets a Boost From BlackRock's Capital
Humana's CenterWell Expansion Gets a Boost From BlackRock's Capital
HUM

Humana Announces New Strategic Joint Venture with BlackRock to Manage CenterWell Senior Primary Care Clinics
Humana Announces New Strategic Joint Venture with BlackRock to Manage CenterWell Senior Primary Care Clinics
HUM

UNH Stock Rises Overnight Ahead Of Earnings: Analyst Outlines ‘Short Premium’ Play To Cut January Call Cost By Nearly 60%
UNH Stock Rises Overnight Ahead Of Earnings: Analyst Outlines ‘Short Premium’ Play To Cut January Call Cost By Nearly 60%
HUM

Humana Inc. to Release Third Quarter 2026 Results on November 6, 2026
Humana Inc. to Release Third Quarter 2026 Results on November 6, 2026
HUM

Strength Seen in Humana (HUM): Can Its 11.6% Jump Turn into More Strength?
Strength Seen in Humana (HUM): Can Its 11.6% Jump Turn into More Strength?
HUM

Humana Hits 95% Four-Star Coverage: What it Means for HUM
Humana Hits 95% Four-Star Coverage: What it Means for HUM
HUM
News tone: automated (AI) classification of the article's content, not a price prediction.
About Humana
Humana Inc. is a for-profit American health insurance company based in Louisville, Kentucky. The firm operates through the following segments: Retail, Group and Specialty and Healthcare Services. The Retail segment consists of products sold on a retail basis to individuals including medical and supplemental benefit plans such as Medicare, and State-based Medicaid contracts
Key Executives
| Name | Title | Year Born |
|---|---|---|
| Mr. James A. Rechtin M.B.A. | President, CEO & Director | 1971 |
| Ms. Celeste Marie Mellet | Chief Financial Officer | 1977 |
| Mr. Japan A. Mehta | Chief Information Officer | 1981 |
| Ms. Michelle A. O'Hara | Chief Human Resources Officer | 1976 |
| Dr. Sanjay K. Shetty M.B.A., M.D. | President of CenterWell | 1974 |
| Mr. John-Paul William Felter | Senior VP, Chief Accounting Officer & Controller | 1983 |
| Mr. Bobby Mukundan | Senior VP & CTO | — |
| Ms. Lisa M. Stoner | Vice President of Investor Relations | — |
| Mr. Joseph C. Ventura | Chief Legal Officer | 1977 |
| Mr. Bruce Dale Broussard | Strategic Advisor | 1962 |
Fundamentals
Valuation
Profitability
Trading
Dividend
Source: third-party data provider, as of October 31, 2026
Technical indicators
- RSI 14
- 53.99
- MACD 12/26/9
- 5.86
- EMA 9 of MACD
- 7.30
- MACD histogram
- -1.44
- SMA 50
- $400.35
- Price above SMA 50
- EMA 50
- $401.41
- Price above EMA 50
- SMA 200
- $307.64
- Price above SMA 200
- EMA 200
- $323.16
- Price above EMA 200
Calculated by Gotrade from daily closing prices, as of October 29, 2026. Technical data, not a recommendation.
Analyst views
10 analyst ratings
Third-party analyst opinion, not a recommendation from Gotrade.
- Low
- $370.00
- Average
- $480.09
- High
- $596.00
Seasonality
Monthly price change (%)| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2021 | -8.7 | +11.1 | ||||||||||
| 2022 | -15.7 | +11.2 | +1.0 | +0.7 | +4.8 | +4.6 | +0.6 | +1.5 | -0.4 | +11.7 | -0.8 | -6.6 |
| 2023 | +2.2 | -3.6 | -2.2 | +4.0 | -6.2 | -13.2 | +2.4 | +0.8 | +5.6 | +6.5 | -0.9 | -7.6 |
| 2024 | -19.6 | -6.8 | -1.5 | -14.0 | +14.0 | +2.6 | -3.2 | -1.3 | -12.9 | -7.7 | +13.7 | -13.4 |
| 2025 | +16.1 | -7.7 | +1.2 | -0.9 | -8.9 | +5.7 | -1.1 | +22.8 | -16.1 | +12.7 | -12.2 | +5.7 |
| 2026 | -26.2 | +1.8 | -7.4 | +33.6 | +30.7 | +21.0 | -11.1 | +2.3 | -3.4 | +10.0 |



